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ABSTRACT 
An Implantable Glucose Sensor Comprised of Optical Assays and a Self-Cleaning Hydrogel 
Membrane 
 
 
Bradley J. Schott 
Department of Biomedical Engineering 
Texas A&M University 
 
 
Research Advisor: Dr. Melissa A. Grunlan 
Department of Biomedical Engineering 
Texas A&M University 
 
 
 An implantable continuous glucose monitor (iCGM) is necessary for diabetic patients to 
keep their glucose levels within a safe range. To build a more accessible iCGM with a longer 
lifetime and cheaper cost, we propose to fabricate an iCGM comprised of an optical glucose 
sensing assay and a “self-cleaning” hydrogel membrane. Previously, “self-cleaning” hydrogels 
exhibited exceptionally thin fibrous capsules and rapid healing in biocompatibility studies in 
vivo. Thus, they are expected to inhibit foreign body responses after implantation, leading to 
iCGMSs with extended lifetime and higher accuracy. In this study, two cost-effective optical 
sensing assays were incorporated into the hydrogel membranes. The encapsulation ability of the 
“self-cleaning” membrane was evaluated, specifically toward small molecules (hydrodynamic 
radius (Dh) <5nm). The preliminary functionality of the glucose sensors comprised of the 
hydrogel membranes and optical assays, were also assessed. By successfully encapsulating the 
optical sensing assay, an iCGM was able to be fabricated as small as a 2 mm x 5 mm cylindrical 
rod (diameter x length).  
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CHAPTER I 
INTRODUCTION 
  
 As of 2017, 30.3 million citizens of the United States have diabetes mellitus, a disease 
characterized by an underproduction of insulin, or by insulin resistance of the body[1]. Close 
regulation of blood glucose levels is vital as extreme deviance from baseline levels can cause 
heart disease, kidney failure, nerve damage, seizures, or even death in extreme cases. Currently, 
the gold standard to track a patient’s glucose level is the finger prick test[2]. However, it is 
inconvenient and painful, while generating discrete values only for the test points. Therefore, a 
continuous glucose monitor (CGM) is necessary to control the glucose changes through time[3]. 
Some CGMs have been approved by the FDA and released into the market. The major 
types of these CGMs are based on a transcutaneous electrochemical sensor, for example, the 
Freestyle Libre® (Abbot)[4]. The Freestyle Libre® is comprised of a hard, transcutaneous sensor 
probe that is indwelled into the patient’s upper arm[5]. Abbot’s Freestyle Libre® measures the 
glucose level in the interstitial fluid and transmit the signal to an outsource device. The hard 
sensor probe and transcutaneous approach generate an active foreign body response which limits 
the functionality of the sensors and their lifetime. Thus, these CGMs are susceptible to infections 
and irritation. They also require frequent replacement of the sensor (3-14 days). Recently, an 
iCGM was approved by the FDA, Eversense® (Senseonics)[6]. It is comprised of a hydrogel 
sensor, optical system, and electrical system within a cylindricallyshaped poly(methyl 
methacrylate) (PMMA) case (18.3 mm x 3.5 mm, length x diameter). To prevent a significant 
foreign body response, it also includes an anti-inflammatory drug delivery component. The 
Eversense® has been approved to be subcutaneously implanted 60-90 days in the patient before 
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replacement with a new sensor. The electrical and optical components are not reusable, which 
increases the cost. They also increase the size of the implant, leading to a higher foreign body 
response. 
Hydrogels are polymeric networks that imbibe large quantities of water[7]. They are 
widely used in biomedical engineering due to their excellent biocompatibility. Previously, a 
thermoresponsive double network hydrogel membrane (DN-25%) was developed as an iCGM 
sensor membrane[8]. It’s comprised of a poly(N-isopropylacrylamide-co-2-acrylamido-2-
methylpropane sulfonic acid) [P(NIPAAm-co-AMPS)] first network, and a PNIPAAm second 
network. The DN-25% membrane is “self-cleaning”. When the temperature fluctuates 
above/below the hydrogels volume phase transition temperature (VPTT), the membrane 
deswells/swells, generating a dynamic anti-biofouling process[9]. An in vivo biocompatibility 
study showed that DN-25% has a minor foreign body response compared to a standard 
biocompatible 10% (w/v) poly(ethylene glycol) (PEG) hydrogel, with thin fibrous encapsulation 
and a fast healing response[10]. 
To build a small-sized iCGM sensor, we proposed to fabricate cylindrical DN-25% 
hydrogel membranes with hollow cavities to incorporate an optical sensing assay. The 
transportation ability of DN-25% permits diffusion of molecules smaller than their mesh sizes 
(Dh ~4 nm – 7 nm)[11]. It allows good diffusion of glucose, yet, it also limits the size of 
molecules that can be housed inside the hydrogel membrane. In this study, one assay 
incorporated was developed by Dr. Gerard L. Coté[11]. It is comprised of phosphor bound 
conanavalin A (PEG-ConA-TRITC) and phosphor bound mannotetraose (APTS-MT). The PEG-
ConA-TRITC can bind to either APTS-MT or glucose, depending on their concentrations. 
Förster resonance energy transfer (FRET) happens when APTS-MT binds with PEG-ConA-
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TRITC, and the intensity decreases when APTS-MT is replaced by glucose[12]. This assay 
allows a sensor size 5 mm x 2.5 mm (length x diameter) with good sensitivity. To successfully 
house APTS-MT (Dh ~3 nm), we utilized a double network hydrogel with controlled mesh size 
by comb architectures. Their housing capability was evaluated with a long-term leaching study.   
Another assay used was developed by Dr. Michael J. McShane[13]. It is comprised of 
phosphorescent molecules [Pd (II) meso-tetra(4-carboxyphenyl)porphine] (PdTCPP) and the 
enzyme glucose oxidase (GOx) in alginate microparticles (D ~ 20 µm)[14]. The phosphorescent 
decay changes with oxygen, which is influenced by glucose oxidation. The alginate 
microparticles were big enough to be directly incorporated into DN-25%. Their functionality was 
briefly evaluated. 
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CHAPTER II 
METHODS 
 
Materials 
 N-isopropylacrylamide (NIPAAm, 97%), 2-acrylamido-2-methylpropane sulfonic acid 
(AMPS, 97%), N-vinylpyrrolidone (NVP, 99%), N,N’-methylenebisacrylamide (BIS, 99%), 1-
[4-(2-Hydroxyethoxy)-phenyl]-2-hydroxy-2-methyl-1-pro-pane-1-one (Irg 2959), cysteamine 
hydrochloride (AET, 98%), methacrylic anhydride (MA, 94%), ammonium persulfate (APS, 
95%), sodium hydroxide (NaOH, 97%), hydrochloric acid (HCl, 37%), fluorescein 
isothiocyanate-dextran (FITC-dextran, 4k, 10k, 20k, and 40k g/mol), ethanol (EtOH, ~99%), and 
acetone (~99.5%) were obtained from Sigma-Aldrich. Potassium hydrogen phosphate (K2HPO4, 
98%) and potassium dihydrogen phosphate (KH2PO4, 98%) were purchased from Alfa Aesar. 
New-Skin Liquid Bandage was obtained from CVS. Phosphate-buffered saline (PBS) was 
purchased from Conrning®. Deionized water (DI H2O) (resistance of 18 MΩ∙cm) was utilized 
for all hydrogel fabrication and all subsequent experiments. 
Hydrogel fabrication 
Double network (DN-25%) hydrogel (hollow rods) 
DN-25% was fabricated as previously reported[15]. The first network precursor solution 
was made with 75:25 (wt:wt) of NIPAAm:AMPS, 4 wt% of BIS and 8 wt% of Irg 2959. It was 
sequentially injected into a cylindrical glass mold with a 400 µm stainless steel wire in the 
middle. The mold was cured under ultraviolet light (UVP UV-Transilluminator, 6 mW cm-2, λpeak 
= 365 nm) for 30 minutes (15 min/side) while immersing in ice to prevent NIPAAm collapse. 
The second network precursor solution was synthesized by combining NIPAAm, NVP, BIS, and 
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Irgacure 2959 in DI. The hollow rods then soaked in the second network for 24 hours and were 
cured again for 10 minutes (5 min/side) with a 650 µm stainless steel wire. 
Poly(AMPS) comb (PAMPS-c-X) hydrogel 
 PAMPS comb hydrogels were fabricated into hollow rods with the same methods as DN-
25%. For the first network precursor solution, X mol% of methacrylated AMPS (PAMPS-MA) 
was added, replacing the same mole of AMPS in the original DN-25% precursor solution (Table 
1). The second network solution was kept the same. PAMPS-MA was synthesized from Dr. 
Melissa Grunlan’s lab as reported[16].  
Table 1: Compositions of all hydrogels tested for fluorescent sensor 
 First Precursor Solution Second Network Solution 
Name NIPAA
m (g) 
AMPS (g) PAMPS-
MA:AMPS 
NIPAAM (g) NVP (g) 
DN-25% 0.75 0.25 0 6 0.96 
PAMPS-c-15% (n=20) 0.75 0.213 15:85 6 0.96 
PAMPS-c-50% (n=5) 0.75 0.125 50:50 6 0.96 
DN-25% hydrogel with PdTCPP alginate microparticles (slab) 
 PdTCPP alginate microparticles were obtained from Dr. McShane’s lab[13] (~1 mg/30 
µL). These microparticles were added into DN-25% first network precursor solution with 
different ratios (2:1, 4:1, 6:1, 8:1, and 10:1). The solution was then injected into a cuboid glass 
mold (1 mm in thickness) and cured under UV for 30 minutes (15 min/side). The mold was 
immersed in ice while curing to prevent NIPAAm collapse. After curing, the hydrogel slab was 
equilibrated in DI for 48 hours to remove unreacted molecules. Sequentially, it was soaked in the 
2nd network for 24 hours and then cured within a cuboid glass mold (1.5 mm in thickness). The 
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mold was then exposed to UV light for 30 minutes (15 min/side) immersed in ice, and stored in 
DI after curing. 
Characterization 
Leaching Study 
 To evaluate the diffusion properties of the hollow rod membrane, FITC-dextran with 
determined sizes (Mw ~4k g/mol and 20k g/mol) was encapsulated in their cavity to perform the 
leaching study[17]. DN-25%, PAMPS-c-50% (n=5), and PAMPS-c-15% (n=20) hollow rods 
(650 µm x 2 mm, inner diameter x outer diameter) were cut into 5 mm long samples. Next, 1.5 
µL of FITC-dextran solution (1 mg/ml) was injected within the cavity. The ends of the rod were 
sealed by inserting one glass bead (~700 µm in diameter) into each end and applying two layers 
of New-Skin® liquid bandage. The rods were then immersed in 500 µL of PBS for one week. 
The accumulative fluorescent intensity of the supernatant was tested every 24 hours with a plate 
reader (Tecan Infinite M2000PRO). The fluorescence of the solution was measured with an 
excitation wavelength of 480 nm and emission wavelength at 520 nm[12]. 
 To evaluate the encapsulation capability of the hollow rod membranes towards APTS-
MT, leaching studies were performed with 1.5 µL APTS-MT solution (2 µM) with an excitation 
and emission wavelength of 490 nm and 520 nm respectively[18]. 
Scanning electron microscopy 
 A few samples of the PdTCPP microparticles from different batches were vacuum dried 
in an oven, sputter-coated (Cressington Sputter Coater 108), and analyzed using a scanning 
electron microscope (NeoScope JCM-500) to characterize particle size distribution. Further 
research showed that sonication of the microparticles was necessary. 
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Sensor functionality test 
 The fluorescent properties of the hydrogel slab with PdTCPP alginate microparticles was 
characterized with the platereader. The excitation and emission wavelengths were 530 and 720 
nm, respectively. 
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CHAPTER III 
RESULTS AND DISCUSSIONS 
 
Leaching study 
 For the FRET-based sensing assay, the Dh of PEG-TRITC-ConA is ~30 nm while APTS-
MT is only ~3 nm[19]. To evaluate the encapsulation capability of the hollow rod membranes, 
FITC-dextran (Mw ~4k g/mol) with similar Dh (~3 nm) to APTS-MT was used for the leaching 
study[17]. As shown in Figure 2, over the course of 6 days, a significant amount of 4k FITC-
dextran leached out of the hollow DN-25% rod within the first day. Hollow rod membranes with 
comb architectures [PAMPS-c-50% (n=5) and PAMPS-c-15% (n=20)] showed improved 
encapsulation. After 24 hours, PAMPS-c-50% (n=5) showed ~75% leaching while PAMPS-c-
15% (n=20) showed ~50% leaching. After six days, ~30% of the FITC-dextran 4k remained in 
the PAMPS-c-15% (n=20) rod. 
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Figure 2: Leaching study performed on DN-25% and PAMPS-comb hydrogel membranes with 4k FITC-dextran 
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 While the results of the leaching tests on the three compositions of hydrogel rods proved 
inconclusive of encapsulation efficiency, the results of the APTS-MT encapsulation were much 
more appealing. Seen below in Figure 3, over the course of four days, there was substantial 
leaching of APTS-MT from the DN-25% and PAMPS-c-50% (n=5); however, the PAMPS-c-
15% (n=20) rod retained ~60% of the APTS-MT implanted. 
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Figure 3: Leaching study performed on DN-25% and PAMPS-comb hydrogel membranes with APTS-MT 
 This leads to the conclusion that the addition of the comb does, in fact, reduce mesh size 
of the hydrogel membrane. Further testing and experimentation need to be done to retain ≥95% 
of APTS-MT implanted before the sensor could be considered for a clinical application, but 
these results are promising. 
Incorporation of microparticles 
PdTCPP alginate microparticles analysis 
 The size of the microparticles developed in Dr. McShane’s lab is substantially larger than 
the mesh size of the DN-25% hydrogel membrane[11]. An original batch of PdTCPP 
microparticles proved rather challenging to work with, resulting in an SEM image of the 
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particles being taken. The image of this batch is shown in Figure 4. Aggregation of the 
microparticles had occurred which made the manufacturing process very difficult. A new batch 
was obtained from Dr. McShane’s lab, sonicated to prevent aggregation, and utilized for all 
further testing. 
              
Figure 4: Scanning Electron Microscopy of aggregated PdTCPP microparticles from the first batch before 
(left) and after (right) sonication. (Scale bars shown for reference) 
 An SEM image of the new batch of PdTCPP microparticles showed an average diameter 
of 9-15 µm (Figure 5). This micromolecule is much too large to diffuse out through the mesh of 
the DN hydrogel membrane, but small enough to work with easily. This preliminary data proves 
promising for incorporation of these microparticles into the DN-25% hydrogel. 
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Figure 5. Scanning Electron Microscopy of PdTCPP microparticles from new batch after sonication at a 
magnification of 600X and a voltage of 10 kV. (Scale bar shown for reference) 
The different slabs with the different concentrations are shown below in Figure 6. 
 
Figure 6: PdTCPP microparticles within DN-25% hydrogel membrane sensor at different concentrations 
 As the concentration of the PdTCPP microparticles decreases, the fluorescent intensity of 
the sensor decreases. Mechanical robustness increases though, as the gel is resembling more of 
the pure DN-25% hydrogel[20]. These two characteristics culminated in the decision to explore 
the 4:1, 6:1, and 8:1 concentrations. 
While incorporation of the microparticles into the DN hydrogel is feasible and 
straightforward, retaining functionality of the sensor proved to be challenging. Figure 7 shows a 
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peak in fluorescent intensity at 720 nm which is indicative of the functionality of the 
microparticles. 
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Figure 7: Fluorescent scan of PdTCPP Alginate Sensor prior to implantation within the DN-25% hydrogel 
membrane 
 However, upon incorporating the microparticles with the double network hydrogel 
membrane, the 720 nm peak shifts to 800 nm (Figure 8). 
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Figure 8: Fluorescent scan of PdTCPP Alginate-DN-25% Sensor after implantation within the DN-25% hydrogel 
membrane 
 A few possible solutions arose as to why the functionality of the sensor was being altered, 
and additional research is necessary to determine what the cause is. Further testing needs to be 
15 
done on the signal-to-noise ratio (SNR) of the PdTCPP DN-25% composition to determine 
whether this shift and reduction in intensity of the peak will prove detrimental to the sensor as a 
whole.  
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CHAPTER IV 
CONCLUSION 
 
Conclusion 
Implantation of a liquid glucose sensing assay within a thermoresponsive “self-cleaning” 
hydrogel membrane has the potential to create an iCGM for diabetes management. 
Leaching studies have shown that the addition of a PAMPS-comb architecture has 
successfully reduced the mesh size of the previously proven DN-25% hydrogel. These results 
lead to believe that the concentration and comb length may be modified, yielding the perfect 
mesh size to allow for glucose diffusion while retaining the slightly larger APTS-MT molecule. 
Further studies will explore different concentrations and length of the PAMPS-comb monomer, 
while also trying to find different encapsulation methods that may prove more effective than the 
current standard. 
Research into the incorporation of glucose sensing microparticles alleviates the issue of 
the sensing assay leaching out through the hydrogel membrane. These phosphorescent-based 
sensors have their emission altered after implantation within the hydrogel; however, an optical 
analyzing system that is able to develop a large enough SNR may be able to yield a blood 
glucose concentration still. Additional testing of functionality needs to be performed by exposing 
the microparticle hydrogel sensor to different concentrations of oxygen to determine whether a 
substantial signal can still be received. Final in vitro testing will include incorporating the GOx 
enzyme and exposing the entire sensing system to a solution of glucose, looking to ensure the 
enzyme is successfully depleting the oxygen present, and the sensor is outputting a proper signal 
to indicate glucose concentration. 
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Future Work 
Another avenue of future research is the use of PD (II) meso-tetra(sulfophenyl) 
tetrabenzoporphyrin sodium salt (S-PdBP) as the microparticle instead of PdTCPP[21]. The new 
microparticles allow for a red light to be used for excitation of the sensor, which penetrates 
through the skin deep enough to reach the sensor, allowing for clinical application[22]. Some 
preliminary testing was done using S-PdBP microparticles (1.83 mg/30 µL). Figure 9 below 
shows the S-PdBP 6:1 hydrogel composition using the same synthesis procedure as the PdTCPP 
alginate sensor, as well as a hollow rod with the microparticle solution within (2:1 S-PdBP:DN-
25% 1st network). Incorporation of the microparticles into either the cavity of a hollow rod or the 
entirety of a solid rod is the ultimate goal as it allows implantation of the rod using a needle 
instead of a surgical procedure. 
 
Figure 9: S-PdBP Alginate Sensor within DN-25% hydrogel membrane sensor and S-PdBP microparticle injected 
within a DN-25% hydrogel hollow rod 
 
  
 
 
5 mm 
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